Expanded Access for Relatlimab
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT05170659
- Status
- No Longer Available
Eligibility Criteria
- Sex
- All
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Relatlimab — DRUG
Study Details
This is an expanded access designed to provide access to Relatlimab for eligible participants.
Key Dates
- First listed
- Dec 28, 2021
- Status verified
- Apr 2022